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The Wae to repair: prostaglandin E2
(PGE2) triggers intestinal wound repair
Rene Jackstadt & Owen James Sansom
Accurate wound repair is a crucial step to
protect organisms from environmental
damage, for example infection and toxin
exposure. In this issue of The EMBO Jour-
nal, Miyoshi et al (2017) have elucidated a
new mechanism underpinning this process
within the intestine where mesenchymal
prostaglandin E2 produced following
damage drives intestinal regeneration.
See also: H Miyoshi et al (January 2017)
T he intestine requires an efficientlyorchestrated repair process given thecontents of the intestinal lumen and
its primary function as an absorptive organ.
Unless damage is repaired quickly, barrier
function would be compromised which
would rapidly lead to infection, sepsis and
ultimately death. After injury, the highly
replicative nature of the intestine leads to
rapid wound closure, to minimize the
exposure to luminal antigens and microor-
ganisms (Peterson & Artis, 2014). However,
given repair/wound healing often activates
many pathways deregulated in cancer, for
example WNT and TGFb, uncontrolled
repair and loss of homoeostasis could lead to
carcinogenesis (Ashton et al, 2010). To guar-
antee proper wound repair, a process termed
epithelial restitution occurs in the intestine
to rapidly reseal superficial injuries (Lacy,
1988). The healing process is most likely to
be performed by a cell population that has
transient repair features, wound-associated
epithelial (WAE) cells, and the induction of
non-canonical Wnt signalling is required
(Stappenbeck & Miyoshi, 2009). WAE cells are
controlled by an orchestra of growth factors
and chemokines. However, both upstream
activators of WAE cells and downstream
effector pathways need to be elucidated.
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Figure 1. Mechanistic model describing the role of PGE2–EP4–PKA–ß-catenin signalling in intestinal
wound repair.
(A) During intestinal injury, PGE2 levels increase locally. This triggers a non-canonical Wnt signalling cascade
resulting in regeneration and wound repair. Pharmacological inhibition or genetic deletion of EP4 impairs this
signalling and the tissue remains refractory for regeneration and wound healing. (B) In vitro organoid
propagation using stem cell medium enables the culture of stem cell rich organoids. Growth factor-depleted but
PGE2-containing medium leads to WAE cell differentiation if cells are EP4 proficient; those cells resemble their
in vivo analogue. EP4 deficiency or pharmacological inhibition of EP4 (iEP4) leads to enterocyte differentiation
and a reduced regenerative capacity.
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In an elegant study, Miyoshi et al (2017)
used a series of models to address this
important question: mouse, organoid and
human cell lines. Transcriptomic profiling
revealed that postmitotic properties of WAE
cells can be generated by growth factor
depletion of intestinal organoids. This
resembles an atypical differentiation state of
WAE cells that has been previously
described during the process of epithelial
reconstitution (Lacy, 1988; Stappenbeck &
Miyoshi, 2009). Importantly, this differentia-
tion state was prostaglandin E2 (PGE2)
dependent. Using a genetically engineered
model for Ptger4 (encoding for the prosta-
glandin E receptor 4, EP4) deletion, the
authors show that PGE2 triggered WAE cell
differentiation is transmitted by EP4 in vitro
and in vivo. In an array of elegant in vitro
assays, the authors could show that the
PGE2–EP4 axis irreversibly leads to WAE cell
differentiation, while inhibition of the PGE2–
EP4 axis leads to enterocyte differentiation.
Mechanistically, the authors describe that
EP4 signalling acts via cAMP–PKA–GSK3b
cascade that controls b-catenin stabilization
(Wnt signalling activity) and eventually dif-
ferentiation to WAE cells. Notably, the
authors demonstrated a concentration-
dependent differentiation into WAE cells,
which may explain the spatial–temporal
appearance of WAE cells during healing. To
note, mesenchymal cells as source for PGE2
have been described by the authors previ-
ously (Manieri et al, 2015).
Cancer has been suggested to be a “wound
that cannot heal” so it is notable that many of
the pathways described here have been
suggested to be important in colorectal
carcinogenesis. Stromal COX2 has been
shown to be important for growth of adeno-
mas in Apc+/ mice, and COX2 produces
Prostaglandin H2 of which Prostaglandin E2
is a downstream metabolite. Loss of EP2 and
EP4 was shown to suppress tumorigenesis in
Apc+/ mice (Sonoshita et al, 2001, 2002)
and, recently, a PGE2–EP4 axis was suggested
to control colon cancer stem cell expansion
and metastasis (Wang et al, 2015).
Taken together, this study using a sophis-
ticated in vitro tool to study wound repair
has generated important new findings into
this process. This in vitro system may also
be able to define many more novel regula-
tors of wound repair. Importantly, trials
have already been performed using EP4
agonist in inflammatory bowel disease
(Nakase et al, 2010). It would be interesting
to assess whether these patients had more
WAE cells and whether they showed
increased wound repair. Conversely, further
work examining the inhibition of the Prosta-
glandin E2–EP4 axis in both the initiation
and progression of colorectal cancer should
provide key insights into the hijacking of
repair processes by cancer cells.
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